Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
2(18%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_4
3
27%
Ph not_applicable
3
27%
Ph phase_3
2
18%
Ph phase_2
2
18%
Ph phase_1
1
9%

Phase Distribution

1

Early Stage

2

Mid Stage

5

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
1(9.1%)
Phase 2Efficacy & side effects
2(18.2%)
Phase 3Large-scale testing
2(18.2%)
Phase 4Post-market surveillance
3(27.3%)
N/ANon-phased studies
3(27.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

50.0%

2 of 4 finished

Non-Completion Rate

50.0%

2 ended early

Currently Active

2

trials recruiting

Total Trials

11

all time

Status Distribution
Active(3)
Completed(2)
Terminated(2)
Other(4)

Detailed Status

unknown3
Recruiting2
Withdrawn2
Completed2
Suspended1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (9.1%)
Phase 22 (18.2%)
Phase 32 (18.2%)
Phase 43 (27.3%)
N/A3 (27.3%)

Trials by Status

recruiting218%
unknown327%
suspended19%
withdrawn218%
not_yet_recruiting19%
completed218%

Recent Activity

2 active trials
Showing 5 of 11
suspendedphase_1

The Safety and Efficacy of Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-ACI) in the Treatment of Acute Cerebral Infarction

NCT03186456
completedphase_3

Efficacy and Safety of Tirofiban for Patients With BAD (BRANT)

NCT06037889
recruitingphase_2

Postpartum Low-Dose Aspirin and Preeclampsia

NCT03667326
withdrawnphase_4

Aggressive Risk-Prevention Therapies for Coronary Atherosclerotic Plaque (ART-CAP)

NCT06280976
withdrawnnot_applicable

Molecular Effects of Aspirin & Metformin on Colonic Epithelium

NCT05158374
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT03186456Phase 1

The Safety and Efficacy of Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-ACI) in the Treatment of Acute Cerebral Infarction

Suspended
NCT06037889Phase 3

Efficacy and Safety of Tirofiban for Patients With BAD (BRANT)

Completed
NCT03667326Phase 2

Postpartum Low-Dose Aspirin and Preeclampsia

Recruiting
NCT06280976Phase 4

Aggressive Risk-Prevention Therapies for Coronary Atherosclerotic Plaque (ART-CAP)

Withdrawn
NCT05158374Not Applicable

Molecular Effects of Aspirin & Metformin on Colonic Epithelium

Withdrawn
NCT06082063Phase 3

Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes

Recruiting
NCT05319834Phase 4

Comparative Study Between Vaginal Progesterone Alone or Combined With Aspirin in Prevention of Recurrent Preterm Birth

Completed
NCT05573958Phase 4

To Assess the Efficacy and Safety of Dual Anticoagulants i.e. Rivaroxaban Plus Aspirin and Clopidogrel Plus Aspirin in Patients Suffering From an Acute Coronary Syndrome

Unknown
NCT05568147Phase 2

Aspirin for Prophylaxis of TTP

Not Yet Recruiting
NCT03821883Not Applicable

Aspirin Discontinuation After Left Atrial Appendage Occlusion in Atrial Fibrillation

Unknown
NCT03306550Not Applicable

Mechanism of Drug-drug Interaction Between Salvianolate Injection and Aspirin

Unknown

All 11 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
11